freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

New prostate cancer drug MDV3100 could soon benefit patients with PMI

Published on 03/11/2011

A new prostate cancer drug could soon be available to patients with private medical insurance (PMI), after a trial of the drug was stopped early thanks to its high success rate. This comes after our report that radiotherapy saves the lives of hundreds of prostate cancer patients.

The latest drug, known as MDV3100, was being tested in a global Phase III trial. 1,200 men took part in the trial. All of these patients had advanced prostate cancer which had previously been treated with chemotherapy, and did not respond to surgical or chemical castration.

The interim results showed that those given MDV3100 lived, on average, 4.8 months longer than those given a placebo. The success of the trial prompted researchers to stop the trial early and offer the active drug to those on the placebo instead.

Professor de Bono, a principal investigator on the AFFIRM trial, said: "To be honest this is a huge advance in prostate cancer medicine."

MDV3100 works by blocking cancer cells’ testosterone receptors. Professor de Bono said: "Five more months in these men, who are at a very, very late stage of cancer, is a huge benefit."

The new drug has been hailed as ‘as important as Herceptin’ in late stage breast cancer patients. A large number of breakthroughs are currently being made towards treating prostate cancer, with a handful of drugs now able to treat the late stages of the disease.

If these early findings are confirmed and the drug is proved safe, then manufacturer Astellas Pharma US will apply for permission to market it in Europe. After that it will ask the National Institute for Health and Clinical Excellence (Nice) to appraise it for prescription on the NHS.

Even if NICE refuses MDV3100 for use on the NHS, patients who already have private medical insurance could have access to this drug on their policy. Compare health insurance quotes online now and choose full cancer cover to ensure that you are covered for MDV3100 when it is awarded a European license.

© ActiveQuote Ltd. 2011

Categories:  Medical
New prostate cancer drug MDV3100 could soon benefit patients with PMIA new prostate cancer drug could soon be available to patients with private medical insurance (PMI), after a trial of the drug was stopp    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...